AI Article Synopsis
Article Abstract
Background: Use of chimeric antigen receptor (CAR) T cells has become a promising strategy in cancer immunotherapy. However, safety in clinical application is also one of the most controversial issues.
Methods: In the present study, we investigated the application of a non-viral site-directed vector (CELiD [closed-ended linear duplex DNA]) dependent on adeno-associated virus (AAV) genomes for the purpose of safe CAR-T engineering. We co-electroporated CD19-CAR encoding "CELiD" vectors with plasmid pCMV-Rep into human T cells and ensured stably transfected CAR-T cells by G418 selection. The efficiency of AAVS1 site-specific integration was analyzed by a real-time polymerase chain reaction.
Results: CAR-T cells engineered by CELiD vectors could be established within 20 days with up to 22.8% AAVS1 site-specific integration efficiency. CAR expression and cytokine secretion of CAR modified T cells were evaluated in vitro. Abundant effector cytokines were produced by the CAR-T cells engineered by CELiD vectors compared to control T cells and the killing efficiency of target cells was estimated to as high as 75% in vitro.
Conclusions: With the help of the AAV-derived CELiD vector, CAR genes were preferentially integrated into the AAVS1 site. This technology could be utilized in human T cell modification and remove the safety constraints of CAR-T therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jgm.3157 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multiplex Genome Editing of Human Pluripotent Stem Cells Using Cpf1.
Bio Protoc
November 2024
Department of Cell and Developmental Biology, School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Targeted genome editing of human pluripotent stem cells (hPSCs) is critical for basic and translational research and can be achieved with site-specific endonucleases. Cpf1 (CRISPR from ) is a programmable DNA endonuclease with AT-rich PAM sequences. In this protocol, we describe procedures for using a single vector system to deliver Cpf1 and CRISPR RNA (crRNA) for genome editing in hPSCs.
View Article and Find Full Text PDFGeneration of Amber Suppression Cell Lines Using CRISPR-Cas9.
Methods Mol Biol
June 2023
Laboratory of Synthetic and Systems Biology, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Karolinska Institutet, Solna, Stockholm, Sweden.
Genetic code expansion via amber suppression allows cotranslational, site-specific introduction of nonnatural chemical groups into proteins in the living cell. The archaeal pyrrolysine-tRNA/pyrrolysine-tRNA synthetase (PylT/RS) pair from Methanosarcina mazei (Mma) has been established for incorporation of a wide range of noncanonical amino acids (ncAAs) in mammalian cells. Once integrated in an engineered protein, ncAAs allow for simple click-chemistry derivatization, photo-cage control of enzyme activity, and site-specific placement of posttranslational modifications.
View Article and Find Full Text PDFIdentification -like locus from the porcine genome and site-specific integration of recombinase-mediated cassette exchange using CRISPR/Cas9.
Anim Biotechnol
December 2023
ToolGen, Inc, Seoul, South Korea.
Gene integration at site-specific loci is a critical approach for understanding the function of a gene in cells or animals. The locus is a well-known safe harbor for human and mouse studies. In this study, we found an -like sequence (p) in the porcine genome using the Genome Browser and designed TALEN and CRISPR/Cas9 to target the p.
View Article and Find Full Text PDFValidation of reliable safe harbor locus for efficient porcine transgenesis.
Funct Integr Genomics
August 2022
Key Laboratory of Applied Technology On Green-Eco-Healthy Animal Husbandry of Zhejiang Province, China-Australia Joint Laboratory for Animal Health Big Data Analytics, Zhejiang Provincial Engineering Laboratory for Animal Health Inspection and Internet Technology, College of Animal Science and Technology, College of Veterinary Medicine, Zhejiang A&F University, 666 Wusu street, Lin'an District, Hangzhou, 311300, Zhejiang, China.
Article Synopsis
- Transgenic technology is commonly used in biomedical and agricultural sectors, but traditional methods can lead to random gene integration with uncertain outcomes.
- This study focused on identifying safe harbor (SH) loci for efficient gene integration in pigs, using CRISPR/Cas9 to test four different SH loci.
- Results indicated that the COL1A1 and ROSA26 loci provided higher expression of a reporter gene (EGFP) and were found to be safer, with minimal impact on neighboring genes and no off-target effects.
Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.
Stem Cell Res Ther
November 2021
Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, Singapore, 117543, Singapore.
Background: Redirection of natural killer (NK) cells with chimeric antigen receptors (CAR) is attractive in developing off-the-shelf CAR therapeutics for cancer treatment. However, the site-specific integration of a CAR gene into NK cells remains challenging.
Methods: In the present study, we genetically modified human induced pluripotent stem cells (iPSCs) with a zinc finger nuclease (ZFN) technology to introduce a cDNA encoding an anti-EpCAM CAR into the adeno-associated virus integration site 1, a "safe harbour" for transgene insertion into human genome, and next differentiated the modified iPSCs into CAR-expressing iNK cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!